Patents by Inventor Chi-Huan Yeh

Chi-Huan Yeh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isoquinoline alkaloid derivative for activating AMP-dependent protein kinase
    Patent number: 9707222
    Abstract: The present invention provides a method for activating the AMP-dependent protein kinase (AMPK) in a subject comprising administering the subject with a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound having the general Formula I, preferably salsolinol or reticuline. The pharmaceutical composition is able to activate AMPK, and thus is effective in the regulation of cell growth and metabolism, and the treatment of AMPK associated diseases.
    Type: Grant
    Filed: September 22, 2014
    Date of Patent: July 18, 2017
    Assignee: ZIH YUAN TANG BIOTECHNOLOGY CO., LTD.
    Inventors: Shoei-Sheng Lee, Ming-Jai Su, Chi-Huan Yeh, Sheng-Fa Tsai, Cheng-Yen Tsai, Chi-Tun Ruan, Chao-Min Hsu
  • Use of isoquinoline derivatives for diabetic wound healing
    Patent number: 9655891
    Abstract: The present invention is related to a method for diabetic wound healing comprising administering to a subject in need thereof a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound having the general Formula I, preferably salsolinol.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: May 23, 2017
    Assignee: ZIH YUAN TANG BIOTECHNOLOGY CO., LTD
    Inventors: Shoei-Sheng Lee, Ming-Jai Su, Chi-Huan Yeh, Chao-Min Hsu
  • APORPHINE ALKALOID DERIVATIVE FOR ACTIVATING AMP-DEPENDENT PROTEIN KINASE
    Publication number: 20150342933
    Abstract: The present invention provides a method for activating the AMP-dependent protein kinase (AMPK) in a subject comprising administering the subject with a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound having the general Formula I, preferably 1,10-dihydroxyaporphine. The pharmaceutical composition is able to activate AMPK, and thus is effective in the regulation of cell growth and metabolism, and the treatment of AMPK associated diseases.
    Type: Application
    Filed: September 22, 2014
    Publication date: December 3, 2015
    Inventors: Shoei-Sheng Lee, Ming-Jai Su, Chi-Huan Yeh, Cheng-Yen Tsai, Chi-Tun Ruan, Chin-Ting Lin, Chao-Min Hsu
  • SECOAPORPHINE ALKALOID DERIVATIVE FOR ACTIVATING AMP-DEPENDENT PROTEIN KINASE
    Publication number: 20150342908
    Abstract: The present invention provides a method for activating the AMP-dependent protein kinase (AMPK) in a subject comprising administering the subject with a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound having the general Formula I, preferably 1,10-dihydroxyaporphine. The pharmaceutical composition is able to activate AMPK, and thus is effective in the regulation of cell growth and metabolism, and the treatment of AMPK associated diseases.
    Type: Application
    Filed: September 22, 2014
    Publication date: December 3, 2015
    Inventors: Shoei-Sheng Lee, Ming-Jai Su, Chi-Huan Yeh, Cheng-Yen Tsai, Chi-Tun Ruan, Chao-Min Hsu
  • ISOQUINOLINE ALKALOID DERIVATIVE FOR ACTIVATING AMP-DEPENDENT PROTEIN KINASE
    Publication number: 20150335634
    Abstract: The present invention provides a method for activating the AMP-dependent protein kinase (AMPK) in a subject comprising administering the subject with a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound having the general Formula I, preferably salsolinol or reticuline. The pharmaceutical composition is able to activate AMPK, and thus is effective in the regulation of cell growth and metabolism, and the treatment of AMPK associated diseases.
    Type: Application
    Filed: September 22, 2014
    Publication date: November 26, 2015
    Inventors: Shoei-Sheng Lee, Ming-Jai Su, Chi-Huan Yeh, Sheng-Fa Tsai, Cheng-Yen Tsai, Chi-Tun Ruan, Chao-Min Hsu